| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 46,212 | 22,856 | ||
| Marketable securities | 173,683 | 78,093 | ||
| Prepaid expenses and other current assets | 1,225 | 5,246 | ||
| Total current assets | 221,120 | 106,195 | ||
| Total property and equipmentat cost | 6,739 | - | ||
| Less accumulated depreciation | 6,620 | - | ||
| Property and equipment, net | 119 | 131 | ||
| Operating lease, right-of-use ('rou') asset | 9,452 | 9,804 | ||
| Restricted cash | 568 | 568 | ||
| Total assets | 231,259 | 116,698 | ||
| Accounts payable | 3,095 | 2,595 | ||
| Accrued expenses | 8,684 | 10,992 | ||
| Operating lease obligations, current portion | 633 | 271 | ||
| Total current liabilities | 12,412 | 13,858 | ||
| Operating lease obligations, long-term portion | 9,234 | 9,633 | ||
| Total liabilities | 21,646 | 23,491 | ||
| Common stock, 0.0001 par value 300,000 shares authorized 177,572 and 137,820 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 53 | 14 | ||
| Additional paid-in-capital | 624,742 | 494,182 | ||
| Accumulated other comprehensive income | 274 | 208 | ||
| Accumulated deficit | -415,456 | -401,197 | ||
| Total stockholders' equity | 209,613 | 93,207 | ||
| Total liabilities and stockholders' equity | 231,259 | 116,698 | ||
Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX)